Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Stachelscheid, Harald  [Clear All Filters]
2023
Ludwik KA, Telugu N, Schommer S, Stachelscheid H, Diecke S. ASSURED-optimized CRISPR protocol for knockout/SNP knockin in hiPSCs. STAR Protoc. 2023;4(3):102406.
Lechner L, Opitz R, Silver MJ, Krabusch PM, Prentice AM, Field MS, Stachelscheid H, Leitão E, Schröder C, Vallone VFernández, et al. Early-set POMC methylation variability is accompanied by increased risk for obesity and is addressable by MC4R agonist treatment. Sci Transl Med. 2023;15(705):eadg1659.
2021
Rössler U, Hennig AFloriane, Stelzer N, Bose S, Kopp J, Søe K, Cyganek L, Zifarelli G, Ali S, von der Hagen M, et al. Efficient generation of osteoclasts from human induced pluripotent stem cells and functional investigations of lethal CLCN7-related osteopetrosis. J Bone Miner Res. 2021.
Cernoch J, Fisch T, Fischer I, Fischer K, Iwanska A, Krüger N, Küchler J, Schaar C, Schommer S, Telugu N, et al. Generation of 20 human induced pluripotent stem cell lines from patients with focal segmental glomerulosclerosis (FSGS). Stem Cell Res. 2021;54:102406.
Schinke C, Vallone VFernandez, Ivanov A, Peng Y, Körtvelyessy P, Nolte L, Huehnchen P, Beule D, Stachelscheid H, Boehmerle W, et al. Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC) -derived sensory neurons. Neurobiol Dis. 2021:105391.
Luo Y, Vallone VFernandez, He J, Frischbutter S, Kolkhir P, Moñino-Romero S, Stachelscheid H, Streu-Haddad V, Maurer M, Siebenhaar F, et al. A novel approach for studying mast cell-driven disorders: mast cells derived from induced pluripotent stem cells. J Allergy Clin Immunol. 2021.
2020
Vallone VFernandez, Telugu NSwamy, Fischer I, Miller D, Schommer S, Diecke S, Stachelscheid H. Methods for Automated Single Cell Isolation and Sub-Cloning of Human Pluripotent Stem Cells. Curr Protoc Stem Cell Biol. 2020;55(1):e123.
2018
Hennig AFloriane, Rössler U, Boiti F, von der Hagen M, Gossen M, Kornak U, Stachelscheid H. Generation of a human induced pluripotent stem cell line (BIHi002-A) from a patient with CLCN7-related infantile malignant autosomal recessive osteopetrosis. Stem Cell Res. 2018;35:101367.